ROHN RIGBY: Open Payments
NPI 1437283553 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,333 in 14 payments from 7 companies in 2025. Trend: 2023 $379 · 2024 $828 · 2025 $2,333
Consulting: $2,130Food & beverage: $203
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $2,185 |
| Corcept Therapeutics | 3 | $70 |
| Acella Pharmaceuticals, LLC | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| Dexcom, Inc. | 1 | $14 |
Products named: Korlym, Wegovy, Ozempic, NP Thyroid 60, FARXIGA, ZEPBOUND, Kerendia, Dexcom G6 Transmitter.
Industry payments across UT — which companies pay providers there.
